# ENDRA Life Sciences Inc.: Form 8-K, filed May 14, 2020

- Company: [ENDRA Life Sciences Inc.](/companies/ndra.md) (CIK 1681682)
- Form: 8-K
- Filed: 2020-05-14
- Accepted by EDGAR: May 14, 2020, 16:04 ET
- Period: 2020-05-14
- Accession: 0001654954-20-005473
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1681682/000165495420005473/ndra_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1681682/000165495420005473/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1681682/000165495420005473/ndra_8k.htm

Filed May 14, 2020.
Source: SEC EDGAR, the filing index for accession 0001654954-20-005473. Last ingested by Listed: Nov 10, 2026, 17:03 ET. No prices; not investment advice.
